Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2019 Publisher: Mercury Pharmaceuticals Limited, Capital House, 85 King William Street, London, EC4N 7BL, UK
Atropine Sulphate 600 micrograms/ml Solution for Injection.
| Pharmaceutical Form |
|---|
|
Clear, colourless, sterile, aqueous solution intended for parenteral administration to human beings. |
Each 1ml of solution contains 600 micrograms of Atropine Sulphate B.P.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Atropine |
Atropine is an antimuscarinic agent which competitively antagonises acetylcholine at postganglionic nerve endings, thus affecting receptors if the exocrine glands, smooth muscle, cardiac muscle and the central nervous system. |
| List of Excipients |
|---|
|
Dilute sulphuric acid BP |
1ml, clear One point cut (OPC) glass ampoules, glass Type I Ph. Eur. Borosilicate glass packed in cardboard cartons to contain 10 × 1ml ampoules.
Mercury Pharmaceuticals Limited, Capital House, 85 King William Street, London, EC4N 7BL, UK
PL 12762/0560
26/02/1991
| Drug | Countries | |
|---|---|---|
| ATROPINE | Nigeria |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
